发明名称 Automation and optimization of CRRT treatment using regional citrate anticoagulation
摘要 A system or method automates and optimizes citrate anticoagulant supplementation in a blood filtration circuit during CRRT. A processor-based control system interfaces with a blood filtration circuit to detect patient blood flow into the circuit, detect fluid loss through a hemofilter, and sense vital electrolyte concentrations in the blood flow, and in response, control the addition of citrate, substitution fluid, and electrolyte supplements to ensure stability of plasma concentrations in post-dilution flow returned to the patient. The controller executes the method embodied as process control algorithms for calculating an optimal citrate flow rate as a function of selected, detected, and calculated system parameters. Citrate may be added to the circuit separately, or as part of a substitution solution or a dialysate.
申请公布号 US8372025(B2) 申请公布日期 2013.02.12
申请号 US20060525800 申请日期 2006.09.21
申请人 BAXTER INTERNATIONAL INC.;BAXTER HEALTHCARE S.A.;LANNOY JEAN-MICHEL 发明人 LANNOY JEAN-MICHEL
分类号 A61M37/00 主分类号 A61M37/00
代理机构 代理人
主权项
地址
您可能感兴趣的专利